Discriminative accuracy of the A/T/N scheme to identify cognitive impairment due to Alzheimer's disease.
Tharick Ali PascoalAntoine LeuzyJoseph TherriaultMira ChamounFiroza LussierCecile TissotOlof StrandbergSebastian PalmqvistErik StomrudPamela C L FerreiraJoão Pedro Ferrari-SouzaRuben SmithAndrea Lessa BenedetSerge GauthierOskar HanssonPedro Rosa-NetoPublished in: Alzheimer's & dementia (Amsterdam, Netherlands) (2023)
In diagnostic settings, the use of A or T neuroimaging biomarkers alone can reduce patient burden and medical costs compared with using their combination, without significantly compromising accuracy.